DE3750348D1 - Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen. - Google Patents

Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.

Info

Publication number
DE3750348D1
DE3750348D1 DE3750348T DE3750348T DE3750348D1 DE 3750348 D1 DE3750348 D1 DE 3750348D1 DE 3750348 T DE3750348 T DE 3750348T DE 3750348 T DE3750348 T DE 3750348T DE 3750348 D1 DE3750348 D1 DE 3750348D1
Authority
DE
Germany
Prior art keywords
plasmid
peptides
myeloma cells
preparation
cells transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750348T
Other languages
English (en)
Other versions
DE3750348T2 (de
Inventor
Kenji Daiichi Seiyaku Murakami
Yasuaki Daiichi Seiyak Tonooka
Norie Daiichi Research I Saito
Kokichi Daiichi Seiya Nakasuji
Norifumi Daiichi Seiy Sugiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3750348D1 publication Critical patent/DE3750348D1/de
Publication of DE3750348T2 publication Critical patent/DE3750348T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE3750348T 1986-04-14 1987-04-14 Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen. Expired - Fee Related DE3750348T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8552786 1986-04-14

Publications (2)

Publication Number Publication Date
DE3750348D1 true DE3750348D1 (de) 1994-09-15
DE3750348T2 DE3750348T2 (de) 1994-12-15

Family

ID=13861362

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750348T Expired - Fee Related DE3750348T2 (de) 1986-04-14 1987-04-14 Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.

Country Status (15)

Country Link
US (1) US5019499A (de)
EP (1) EP0244677B1 (de)
JP (1) JP2573215B2 (de)
KR (1) KR960007195B1 (de)
CN (2) CN1034427C (de)
AT (1) ATE109827T1 (de)
AU (1) AU600481B2 (de)
CA (1) CA1297434C (de)
DE (1) DE3750348T2 (de)
DK (1) DK189987A (de)
FI (1) FI97550C (de)
IE (1) IE65500B1 (de)
IL (1) IL82207A (de)
NO (1) NO175872C (de)
PH (1) PH26343A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622870B2 (en) * 1987-08-07 1992-04-30 Medical Research Council, The Vector for integration site independent gene expression in mammalian host cells
US5879936A (en) * 1988-04-18 1999-03-09 Aluguisse Holding A.G. Recombinant DNA methods, vectors and host cells
GB8809129D0 (en) * 1988-04-18 1988-05-18 Celltech Ltd Recombinant dna methods vectors and host cells
US5573937A (en) * 1989-12-07 1996-11-12 Snow Brand Milk Products Co., Ltd. Serum free culture medium
US5891693A (en) * 1990-01-25 1999-04-06 Alusuisse Holdings A.G. Recombinant DNA methods vectors and host cells
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
EP0798379A3 (de) * 1996-03-29 1999-10-06 Tosoh Corporation Myeloma Zell-Linie die die menschliche Glutaminsäuredekarboxylase exprimiert
UY26317A1 (es) * 2000-08-30 2000-10-31 Alfonso Cayota Carlos Pritsch Sistema de produccion de trombopoyetina humana por celulas de mamiferos en cultivo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572108B2 (en) * 1983-01-19 1988-05-05 Genentech Inc. Human tpa production using vectors coding for dhfr protein
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
US4740461A (en) * 1983-12-27 1988-04-26 Genetics Institute, Inc. Vectors and methods for transformation of eucaryotic cells
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
JPS6147500A (ja) * 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
JPS61134325A (ja) * 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
JPS61134324A (ja) * 1984-12-04 1986-06-21 Teijin Ltd ヒト抗体ｈ鎖遺伝子の発現方法
JP2532858B2 (ja) * 1985-04-01 1996-09-11 セルテツク リミテツド 形質転換したミエロ―マ細胞系
JPH0714341B2 (ja) * 1985-11-20 1995-02-22 鐘淵化学工業株式会社 蛋白質の高生産株の取得方法
JP2581668B2 (ja) * 1985-11-27 1997-02-12 三井東圧化学株式会社 ヒト正常細胞由来のヒト組織プラスミノ−ゲン活性化因子をコ−ドする新しいｄｎａ配列とそれを含むベクタ−及び細胞
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product

Also Published As

Publication number Publication date
JPS6344897A (ja) 1988-02-25
IL82207A (en) 1992-03-29
PH26343A (en) 1992-04-29
FI97550C (fi) 1997-01-10
DK189987D0 (da) 1987-04-13
AU7151687A (en) 1987-10-15
FI97550B (fi) 1996-09-30
DE3750348T2 (de) 1994-12-15
CN1034427C (zh) 1997-04-02
EP0244677A3 (en) 1988-08-03
FI871607A (fi) 1987-10-15
KR870010190A (ko) 1987-11-30
CN87102823A (zh) 1987-11-04
IL82207A0 (en) 1987-10-30
EP0244677A2 (de) 1987-11-11
EP0244677B1 (de) 1994-08-10
US5019499A (en) 1991-05-28
CN1107513A (zh) 1995-08-30
CA1297434C (en) 1992-03-17
FI871607A0 (fi) 1987-04-13
JP2573215B2 (ja) 1997-01-22
IE870952L (en) 1987-10-14
AU600481B2 (en) 1990-08-16
KR960007195B1 (ko) 1996-05-29
NO871573D0 (no) 1987-04-14
NO871573L (no) 1987-10-15
ATE109827T1 (de) 1994-08-15
IE65500B1 (en) 1995-11-01
DK189987A (da) 1987-10-15
NO175872B (de) 1994-09-12
NO175872C (no) 1994-12-21

Similar Documents

Publication Publication Date Title
DE69518910D1 (de) Verfahren zur herstellung von viralen vektoren von mindestens 20kb durch intermolekulare homologe rekombination in einer prokaryotischen zelle
FI104261B1 (fi) Menetelmä yhdistelmä ihmisen erytropoietiinin tuottamiseksi
DE68928892D1 (de) Rekombinante DNA, transformierte Mikroorganismen, Pflanzenzellen und Pflanzen, Verfahren zur Einführung einer induzierbaren Eigenschaft in Pflanzen und Verfahren zur Herstellung eines Polypeptids oder Proteins mit Hilfe von Pflanzen oder Pflanzenzellen
DE68925083D1 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
KR880701288A (ko) M-csf의 제법
ATE256182T1 (de) Neuartiges p- selectin ligandenprotein
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
WO2000034474A3 (en) Growth factor homolog zvegf3
DE3750348D1 (de) Verfahren zur Herstellung von Peptiden, dazu zu verwendendes rekombinantes Plasmid und mit diesem Plasmid transformierte Myelomzellen.
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
DE3751368D1 (de) gentechnische Herstellung von Faktor XIIIa.
JPS6420095A (en) Polypeptide having anti-blood coagulating action
ATE209252T1 (de) Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
ATE196165T1 (de) Methoden zur herstellung von protein c
DE3587205D1 (de) Verfahren zur herstellung eines proteins und dafuer zu verwendender vektor, rekombinante dns und transformierte zelle.
ATE139568T1 (de) Achromobacter-protease-i-gen sowie genprodukt
JPS6420086A (en) Polypeptide and production thereof
KR890008166A (ko) 융합 단백질의 선택적 분해 방법
DE3767629D1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.
KR950018453A (ko) 콜라게네이즈 인지부위를 가진 재조합 인간 성장 호르몬

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee